Professor of Pharmaceutical Sciences & Dean of the College of Pharmacy
Julie Johnson is a leader in the field of personalized medicine, particularly for cardiovascular treatment.
Now dean of the UF College of Pharmacy, Johnson continues her research into how genes influence individual patients’ responses to important cardiovascular drugs, including blood thinners and medications regulating blood pressure.
In June 2012, UF Health began using a blood test to determine whether cardiac catheterization patients should be administered clopidogrel, a commonly prescribed anti-clotting drug, and found that approximately 28 percent have a genetic variation indicating a different medication should be used.
The healthcare system is now storing this information in patient medical records and expanding the research to other medications.